ANTI-CLQ COLUMN: LIGAND SPECIFIC PURIFICATION OF IMMUNE COMPLEXES FROM HUMAN SERUM OR PLASMA. ANALYSIS OF THE INTERACTION BETWEEN CLQ AND IMMUNE COMPLEXESKILGALLON W; AMLOT PL; WILLIAMS BD et al.1982; CLINICAL AND EXPERIMENTAL IMMUNOLOGY; ISSN 0009-9104; GBR; DA. 1982; VOL. 48; NO 3; PP. 705-714; BIBL. 22 REF.Article

IMMUNOLOGICAL RESPONSIVENESS AFTER TRANSURETHRAL RESECTION OF THE PROSTATE: GENERAL VERSUS SPINAL ANAESTHETICWHELAN P; MORRIS PJ.1982; CLINICAL AND EXPERIMENTAL IMMUNOLOGY; ISSN 0009-9104; GBR; DA. 1982; VOL. 48; NO 3; PP. 611-618; BIBL. 17 REF.Article

KINETICS OF INTERACTION OF IMMUNE COMPLEXES WITH COMPLEMENT RECEPTORS ON HUMAN BLOOD CELLS: MODIFICATION OF COMPLEXES DURING INTERACTION WITH RED CELLSMEDOF ME; PRINCE GM; OGER JJF et al.1982; CLINICAL AND EXPERIMENTAL IMMUNOLOGY; ISSN 0009-9104; GBR; DA. 1982; VOL. 48; NO 3; PP. 715-725; BIBL. 28 REF.Article

SEGREGATION OF AUTOANTIBODY TO CYTOSKELETAL FILAMENTS, ACTIN AND INTERMEDIATE FILAMENTS WITH TWO TYPES OF CHRONIC HEPATITISPEDERSEN JS; TOH BH; MACKAY IR et al.1982; CLINICAL AND EXPERIMENTAL IMMUNOLOGY; ISSN 0009-9104; GBR; DA. 1982; VOL. 48; NO 3; PP. 527-532; BIBL. 18 REF.Article

DEFECTIVE B CELL FUNCTION IN SYSTEMIC LUPUS ERUTHEMATOSUSPELTON BK; DENMAN AM.1982; CLINICAL AND EXPERIMENTAL IMMUNOLOGY; ISSN 0009-9104; GBR; DA. 1982; VOL. 48; NO 3; PP. 513-518; BIBL. 27 REF.Article

GYM ALLOTYPES AND IGG SUBCLASS LEVELS IN IRAQI ARABSSHAKIB F; JAMES K; BARR D et al.1982; JOURNAL OF IMMUNOGENETICS; ISSN 0305-1811; GBR; DA. 1982; VOL. 9; NO 3; PP. 149-153; BIBL. 11 REF.Article

HETEROGENEITY OF CONCANAVALIN A-INDUCED SUPPRESSOR T CELLS IN MAN DEFINED WITH MONOCLONAL ANTIBODIESDAMLE NK; GUPTA S.1982; CLINICAL AND EXPERIMENTAL IMMUNOLOGY; ISSN 0009-9104; GBR; DA. 1982; VOL. 48; NO 3; PP. 581-588; BIBL. 23 REF.Article

THE NATURE OF THE AUTOANTIBODY RESPONSE TO THYROGLOBULIN IN MURINE STRAINS WITH HIGH OR LOW SUSCEPTIBILITY TO THE EXPERIMENTAL INDUCTION OF AUTOIMMUNE THYROIDITISDE CARVALHO LCP; ROITT IM.1982; CLINICAL AND EXPERIMENTAL IMMUNOLOGY; ISSN 0009-9104; GBR; DA. 1982; VOL. 48; NO 3; PP. 519-526; BIBL. 17 REF.Article

INTERFERONS AS ANTITUMOR AGENTSKIRCHNER H.1982; JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY; ISSN 0171-5216; DEU; DA. 1982; VOL. 103; NO 1; PP. 1-6; BIBL. 25 REF.Article

HYPOBETALIPOPROTEINEMIC AGENTS. III: VARIATIONS OF THE POLYCYCLIC PROTEIN OF 4-(1-ADAMANTYLOXY) ANILINEHEYD WE; BELL LT; HEYSTEK JR et al.1982; JOURNAL OF MEDICINAL CHEMISTRY; ISSN 0022-2623; USA; DA. 1982; VOL. 25; NO 9; PP. 1101-1103; BIBL. 12 REF.Article

CYTOGENETIC CHANGES DURING TUMOR PROGRESSION TOWARDS INVASION, METASTASIS AND IMMUNE ESCAPE IN THE EB/ESB MODEL SYSTEMDZARLIEVA R; SCHIRRMACHER V; FUSENIG NF et al.1982; INTERNATIONAL JOURNAL OF CANCER; ISSN 0020-7136; CHE; DA. 1982; VOL. 30; NO 5; PP. 633-642; BIBL. 1 P.Article

SEROTHERAPY OF L1210 MURINE LEUKAEMIA - REASONS FOR INEFFECTIVENESS OF IN VIVO TREATMENT BY L.1 MONOCLONAL ANTIBODY = SEROTHERAPIE DE LA LEUCEMIE MURINE L1210 - RAISONS DE L'INEFFICACITE DU TRAITEMENT IN VIVO PAR ANTICORPS MONOCLONAL L.1TESTORELLI C; CANTI G; FRANCO P et al.1983; BRITISH JOURNAL OF CANCER; ISSN 0007-0920; GBR; DA. 1983; VOL. 47; NO 3; PP. 353-359; ABS. ENG; BIBL. 21 REF.; GRAPHArticle

ADJUVANT IMMUNOTHERAPY AFTER SURGERY AND RADIOTHERAPY FOR BREAST CARCINOMAPAPAVASILIOU C; PAPPAS J; PAVLATOU M et al.1982; STRAHLENTHERAPIE; ISSN 0039-2073; DEU; DA. 1982; VOL. 158; NO 4; PP. 206-209; ABS. GER/FRE; BIBL. 15 REF.Article

MANIPULATION OF HOST DEFENCE MECHANISMSAOKI T ED; URUSHIZAKI I ED; TSUBURA E ED et al.1981; EXCERPTA MEDICA. INTERNATIONAL CONGRESS SERIES; ISSN 0531-5131; NLD; DA. 1981; NO 576; PP. 1-281; BIBL. DISSEM.Serial Issue

ZUR IMMUNTHERAPIE BOESARTIGER GESCHWUELSTE = IMMUNOTHERAPIE DES TUMEURS MALIGNESGERICKE D.1979; PRAXIS KLIN. PNEUMOL.; DEU; DA. 1979; VOL. 33; SUPPL. 1; PP. 350-357; ABS. ENG; BIBL. 3 P.Article

A CRITICAL EXAMINATION OF THE FOUNDATIONS OF IMMUNOTHERAPY FOR CANCERHEWITT HB.1979; CLIN. RADIOL.; GBR; DA. 1979; VOL. 30; NO 4; PP. 361-369; BIBL. 2 P.Article

IMMUNTHERAPIE MIT DNCB BEI MYKOSIS FUNGOIDES. = IMMUNOTHERAPIE PAR LE DNCB DANS LE MYCOSIS FONGOIDEWATZIG V.1977; DERMATOL. MONATSSCHR.; DTSCH.; DA. 1977; VOL. 163; NO 1; PP. 56-57; BIBL. 14 REF.Article

PROSPECTIVE THERAPEUTIQUE: SEROTHERAPIES SPECIFIQUES AU COURS DES INTOXICATIONS AIGUES A HAUTE LETHALITEBAUD FREDERIC JOSEPH.sd; FRA; DA. S.D.; 171; 392 P.; 30 CM; BIBL. 199 REF.; TH.: MED./PARIS 7/1978Thesis

PHOSPHOLIPASE ACTIVATION IN THE IGE-MEDIATED AND CA²⁺ IONOPHORE A23187-INDUCED RELEASE OF HISTAMINE FROM RAT BASOPHILIC LEUKEMIA CELLSMCGIUNEY A; MORITA Y; CREWS FT et al.1981; ARCH. BIOCHEM. BIOPHYS.; ISSN 0003-9861; USA; DA. 1981; VOL. 212; NO 2; PP. 572-580; BIBL. 26 REF.Article

CONFERENCE ON IMMUNE MODULATION AND CONTROL OF NEOPLASIA BY ADJUVANT THERAPY. 4. PROCEEDINGS1978; CANCER TREATM. REP.; USA; DA. 1978; VOL. 62; NO 11; PP. 1609-1996; BIBL. DISSEM.Conference Paper

IMMUNTHERAPIE BEI VIRUSKRANKHEITEN DER HAUT. = IMMUNOTHERAPIE DES VIROSES CUTANEESWUTHRICH B.1978; SCHWEIZ. MED. WSCHR.; SCHWEIZ; DA. 1978; VOL. 108; NO 3; PP. 77-81; BIBL. 28 REF.Article

IMMUNOTHERAPY IN THE TREATMENT OF CANCER.ROBERTS JA.1977; SCOTT. MED. J.; G.B.; DA. 1977; VOL. 22; NO 4; PP. 320-330; BIBL. 3 P. 1/2Article

OF CAVIES AND MEN: THE PROPRIETY AND RATIONALITY OF "CANCER IMMUNOTHERAPY".RAPP HJ.1977; J. NATION. CANCER INST.; U.S.A.; DA. 1977; VOL. 59; NO 6; PP. 1577-1579; BIBL. 16 REF.Article

THE CURRENT STATUS OF CLINICAL IMMUNOTHERAPY AS VIEWED AT THE 1976 AACR-ASCO MEETINGS.CARTER SK.1976; CANCER IMMUNOL. IMMUNOTHERAPY; GERM.; DA. 1976; VOL. 1; NO 4; PP. 275-281Article

IMMUNOTHERAPY-IMMUNOMODULATIONPATTERSON R; NORMAN P; VAN METRE T et al.1982; JAMA, J. AM. MED. ASSOC.; ISSN 0098-7484; USA; DA. 1982; VOL. 248; NO 20; PP. 2759-2772; BIBL. 21 REF.Article